Bone Cancer Trial Results
Experimental Drug for Osteosarcoma Improves Overall Survival
(Posted: 03/04/2008) - Patients with osteosarcoma who received the experimental drug mifamurtide (L-MTP-PE) along with chemotherapy fared better than patients who received chemotherapy alone, according to the Feb. 1, 2008, Journal of Clinical Oncology.
![](https://webarchive.library.unt.edu/web/20121002003316im_/http://www.cancer.gov/images/spacer.gif)
(Posted: 03/04/2008) - Patients with osteosarcoma who received the experimental drug mifamurtide (L-MTP-PE) along with chemotherapy fared better than patients who received chemotherapy alone, according to the Feb. 1, 2008, Journal of Clinical Oncology.
![](https://webarchive.library.unt.edu/web/20121002003316im_/http://www.cancer.gov/images/spacer.gif)